While it's true that AusCann announced the clinical trials. It's is debatable that they actually are doing trials. They did what I predicted would happened which was to put the product out informally to early adopters (doctors) to test on potential users. It is not a controlled trial in any shape and form. The result will be just subjective reports of very little value and not backed up by independent experts.
Why Ido left? Who knows. Australia is safer than other parts of the world during covid-19 time. The fact that AusCann managed to keep so much cash means it spent very little (also meant it was doing very little). That is what keeping the share price from sinking under 16c. I think it is ok to do a bit of speculation. Look at other cannabis companies! Their share prices have been smashed! Last time I bought a little for 19c but quickly sold it for a little profit. Now I bought a little at 17c.
I think there is a chance to make some money but I don't stay over my welcome in this stock.
AC8 Price at posting:
17.0¢ Sentiment: None Disclosure: Held
